Diagnostic imaging, outpatient, and cancer care services provider Affidea and imaging artificial intelligence (AI) software developer Subtle Medical have formed a strategic partnership to improve the patient experience during PET/CT scans.
The companies plan to utilize AI-powered SubtlePET technology, which is designed to enable faster PET scans with no degradation in image quality, at Affidea's IRMET PET/CT center in Italy for patients who have difficulty remaining still for long periods of time. With the technology, the center can also improve its workflow productivity and decrease the waiting list for patients, the companies said.
SubtlePET has received the CE Mark in Europe, in addition to clearance from the U.S. Food and Drug Administration.
